Apogee Therapeutics (APGE) Earnings Date, Estimates & Call Transcripts → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free APGE Stock Alerts $49.00 +1.87 (+3.97%) (As of 04/29/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJun. 4EstimatedActual EPS (Mar. 5) -$0.32 Beat By $0.13 Consensus EPS (Mar. 5) -$0.45 Get Apogee Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for APGE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAPGE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.APGE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Apogee Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.70)($0.70)($0.70)Q2 20241($0.71)($0.71)($0.71)Q3 20241($0.73)($0.73)($0.73)Q4 20241($0.74)($0.74)($0.74)FY 20244($2.88)($2.88)($2.88)APGE Earnings Date and InformationApogee Therapeutics last issued its quarterly earnings data on March 5th, 2024. The reported ($0.32) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.45) by $0.13. Apogee Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Apogee Therapeutics are expected to decrease in the coming year, from ($2.67) to ($3.06) per share. Apogee Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 4th, 2024 based off prior year's report dates.Read More Apogee Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/4/2024Estimated)------- 3/5/2024Q4 2023($0.45)($0.32)+$0.13($0.32)--11/13/2023Q3 2023($0.43)($0.51)($0.08)($0.51)--8/28/2023Q2 2023($2.49)($3.78)($1.29)($3.78)-- Apogee Therapeutics Earnings - Frequently Asked Questions When is Apogee Therapeutics's earnings date? Apogee Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 4th, 2024 based off last year's report dates. Learn more on APGE's earnings history. Did Apogee Therapeutics beat their earnings estimates last quarter? In the previous quarter, Apogee Therapeutics (NASDAQ:APGE) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.13. Learn more on analysts' earnings estimate vs. APGE's actual earnings. How much profit does Apogee Therapeutics generate each year? Apogee Therapeutics (NASDAQ:APGE) has a recorded net income of -$83.99 million. APGE has generated $0.00 earnings per share over the last four quarters. What is Apogee Therapeutics's EPS forecast for next year? Apogee Therapeutics's earnings are expected to decrease from ($2.67) per share to ($3.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Arcellx Earnings Immunocore Earnings SpringWorks Therapeutics Earnings Iovance Biotherapeutics Earnings ImmunityBio Earnings Denali Therapeutics Earnings Kymera Therapeutics Earnings Vericel Earnings Ginkgo Bioworks Earnings Beam Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:APGE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
